MBM Future Health
Berlin, Germany · Business Services
This profile has not been verified by the business owner.
Information may be incomplete or outdated.
#scientific consultation
#amnog
#rare diseases
#benefit assessment
#evidence-based decision making
#orphan drugs
#access to medicines
#german hta
#market access
#gene therapy
Overview
MBM Future Health, Access to Innovative Medicines
MBM Future Health offers strategic advice for international stakeholders on access to novel medicines.
Public Health and evidence-based decision-making have been the centre of my work for 20 years, almost 10 years at Germany’s top health policy body, the G-BA.
My particular focus for 15 years has been on rare diseases, including cell and gene therapies. A challenge I currently tackle is the use of real-world data, balancing opportunities and risks of AI.
I am pleased to offer you strategic regulatory advice to ensure that patients get access to the best possible new medicines.
For rare diseases and other neglected diseases. Overall, for the best possible treatments in challenging indications.
Let's work together!
Contact Details
info@mbm-futurehealth.com
Berlin, Germany
Employees
2-10
Keywords
#scientific consultation
#amnog
#rare diseases
#benefit assessment
#evidence-based decision making
#orphan drugs
#access to medicines
#german hta
#market access
#gene therapy
Companies teams usually look at after MBM Future Health
Comparing a few options usually leads to better decisions
Save companies to compare later. Useful when sharing options with your team
This is how your company profile looks to others.